Battling Cancer one test at a time

---

According to the World Health Organization, 7.6 million people die of Cancer each year. In the Philippines cancer is the 3rd leading cause of death causing physical, emotional and financial stress to the victims and their families.

Early detection of cancer greatly increases the chances of a successful treatment. In the past, if you were worried about having cancer, there was no simple test to take. Most cancer victims, even high-risk ones, were not tested for cancer until they showed symptoms of the disease. By then, it was usually too late.

Times have changed. Pharmacanada™ provides Early Cancer Detection (ECD) tests designed to check for early-stage cancer in high-risk individuals.

Pharmacanada™ provides Early Cancer Detection (ECD) through ClearCyte™ Technology, engendered by research at the British Columbia Cancer Agency. It is the analysis of DNA in liquid-based specimen through the utilization of an automated Cytometry Technology that captures, measures & sorts imaged cell nuclei to DNA ploidy & other nuclear features necessary for the detection of cancerous & preccancerous conditions.

Early detection is proven to reduce mortality from all types of cancer, especially for those at high risk of developing the disease. Discovering cancer early means better prognoses and more successful treatment outcomes.